Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
Inactive · Last trade price on Aug 20, 2025
Accelerate Diagnostics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -50.05 | -61.62 | -62.49 | -77.7 | -78.21 |
Depreciation & Amortization | 3.42 | 3.25 | 3 | 2.52 | 3 |
Other Amortization | 8.68 | 4.31 | 1.31 | 11.54 | 11.17 |
Loss (Gain) From Sale of Assets | 0.2 | 0.15 | 0.13 | -0.08 | 0.79 |
Loss (Gain) From Sale of Investments | -0.07 | -0.11 | 0.31 | 0.23 | 0.1 |
Stock-Based Compensation | 4.38 | 5.39 | 10.63 | 22.05 | 16.46 |
Provision & Write-off of Bad Debts | 0.35 | 0.3 | 0.2 | 0.12 | - |
Other Operating Activities | 6.29 | 3.2 | -3.57 | -5.29 | - |
Change in Accounts Receivable | 0.44 | -0.23 | -0.1 | -0.89 | 1.59 |
Change in Inventory | -0.05 | 0.45 | -0.24 | -0.42 | -1.36 |
Change in Accounts Payable | 0.79 | 0.3 | 2.92 | 0.27 | -1.01 |
Change in Unearned Revenue | 1.25 | 2.12 | 0.1 | 0.08 | 0.11 |
Change in Other Net Operating Assets | 0.16 | 2.31 | -0.93 | 0.25 | -3.04 |
Operating Cash Flow | -24.19 | -40.2 | -48.73 | -47.32 | -50.39 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.51 | -1.04 | -0.55 | -0.6 | -1.36 |
Investment in Securities | - | 9.7 | 12.97 | 8.91 | 14.97 |
Investing Cash Flow | -0.51 | 8.66 | 12.42 | 8.3 | 13.61 |
Financing Activities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | 25.23 | 10 | - | - | 5.58 |
Long-Term Debt Repaid | -1.45 | -1.25 | -1.28 | -0.36 | -0.37 |
Net Debt Issued (Repaid) | 23.78 | 8.75 | -1.28 | -0.36 | 5.21 |
Issuance of Common Stock | 5.27 | 4 | 33.1 | 34.67 | 6.42 |
Repurchase of Common Stock | - | - | - | -20.3 | - |
Other Financing Activities | -2 | -3.73 | -0.19 | -1.24 | - |
Financing Cash Flow | 27.05 | 9.02 | 31.63 | 43.23 | 11.63 |
Net Cash Flow
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | 0.61 | -0.25 | -0.31 | -0.09 | -0.08 |
Net Cash Flow | 2.96 | -22.77 | -4.99 | 4.12 | -25.23 |
Free Cash Flow
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -24.7 | -41.23 | -49.28 | -47.93 | -51.76 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -211.17% | -341.91% | -386.47% | -406.77% | -463.56% |
Free Cash Flow Per Share | -1.06 | -3.31 | -6.00 | -7.76 | -9.24 |
Levered Free Cash Flow | -4.67 | -25.94 | -25.97 | -14.65 | -22.12 |
Unlevered Free Cash Flow | -5.15 | -25.41 | -24.92 | -16.48 | -23.57 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Interest Paid | 0.03 | 0.12 | 2.21 | 4.29 | 4.29 |
Cash Income Tax Paid | - | 0.36 | - | - | 0.04 |
Change in Working Capital | 2.59 | 4.93 | 1.75 | -0.71 | -3.7 |